Browse Category

Stock Market News 21 October 2025

Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Stock Soars on Major Funding News Minerva Neurosciences’ stock chart went vertical on Tuesday after the biotech announced an expansive financing deal that effectively triples the company’s market capitalization overnightmarketbeat.com. In pre-market trading on Oct. 21, NERV stock jumped as much as 160% on the newsgurufocus.com. The shares opened around $6–7 (up from ~$2.66 prior close) and oscillated near those levels through the day, ultimately marking a 52-week high of $6.97marketbeat.com. By comparison, NERV had traded as low as $1.15 within the past yearmarketbeat.com, reflecting both the dramatic rebound and the extreme volatility inherent in this micro-cap biotech. Such a
21 October 2025
Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Experts expect the MN8/Eos deal to catalyze further investment in long-duration storage. Data-center operators and grid planners alike see value in pairing renewables with dispatchable storage. “We can create efficiency when those [projects] are co-located,” says Eran Mahrer of Leeward Renewable Energy reuters.com, reflecting a broader push for integrated solar-storage sites. With lawmakers keen on grid resilience, analysts believe U.S. demand for safe, scalable solutions like Eos’s will grow sharply over the next 5–10 years reuters.com energy-storage.news. The big question is execution: if Eos can convert its pipeline into projects as planned, its zinc batteries could help power a new
21 October 2025
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Deal Details and Company Background Hologic (NYSE: HOLX) is a Marlborough, MA–based medical technology firm focused on women’s health. Its products include mammography and breast biopsy systems, cervical cancer tests, surgical equipment (notably after its acquisition of Gynesonics), and lab diagnostics including molecular tests for Covid-19 bostonglobe.com. The Blackstone/TPG consortium will buy all outstanding Hologic shares for $76 cash plus a $3 CVR (contingent on hitting revenue goals in 2026–27 for the breast health business) marketscreener.com. This values the deal at $79 per share maximum and around $18.3 billion total enterprise value marketscreener.com. The purchase price represents a roughly 46%
Sunrun (RUN) Stock Soars 5% to 12-Month High on Analyst Upgrades and Solar Incentives

Sunrun (RUN) Stock Soars 5% to 12-Month High on Analyst Upgrades and Solar Incentives

Stock Rallies on Upbeat Sentiment On Oct. 21, 2025, Sunrun (Nasdaq: RUN) traded around $20.50, up about 5% intraday reuters.com. This surge followed news that Wall Street’s Citigroup had upgraded Sunrun to “Buy” with a $26 price target marketbeat.com. The stock’s rally pushed it above the consensus 12-month analyst target (~$20) ts2.tech. In fact, RUN hit a new 12-month high (~$20.25) on Oct. 7 markets.financialcontent.com, as investors cheered its improving fundamentals and solar incentives. Over the year, Sunrun has been on a tear. Earlier in 2025, the shares languished near multi-year lows (around $5.38), but rallied into the teens after
AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

SPAC Structure and Acquisition Target AlphaVest Acquisition Corp is a special-purpose acquisition company (SPAC) – a “blank check” issuer that raised capital through an IPO to merge with a private company stockanalysis.com globenewswire.com. It has no business operations of its own; its entire asset is cash held in a trust. SPAC shareholders typically get stock in the merged company or can redeem their shares for cash (the trust value) if the deal fails. AlphaVest’s announced target is AMC Corporation, a Washington-based technology company specializing in AI-driven security and safety solutions marketscreener.com. AMC has developed products like YI-brand smart cameras and
RTX Stock Skyrockets: Aerospace & Defense Boom Sends Q3 Results and 2025 Forecast Soaring

RTX Stock Skyrockets: Aerospace & Defense Boom Sends Q3 Results and 2025 Forecast Soaring

Blowout Q3 Earnings On Oct. 21, RTX reported a blowout quarter. Total sales jumped 12% year-over-year to $22.48 billion globalbankingandfinance.com, handily above the ~$21.3B Wall Street estimate. Adjusted earnings came in at $1.70 per share, well above the consensus ~$1.41 globalbankingandfinance.com investing.com. The results were driven by strength across its portfolio: Collins Aerospace revenues hit $7.62B (+8%), and Pratt & Whitney engine sales rose 16% to $8.42B (boosted by surging Airbus A320neo orders) globalbankingandfinance.com. RTX’s defense unit (legacy Raytheon) reported a 10% jump in sales, “predominantly from higher sales for its Patriot air defense systems” being used in Ukraine globalbankingandfinance.com.
21 October 2025
Apple’s iPhone 17 BOOM: Sales Surge, Stock Soars Near $4T – What Analysts Say

Apple’s iPhone 17 BOOM: Sales Surge, Stock Soars Near $4T – What Analysts Say

Apple Inc. (NASDAQ: AAPL) is riding high on the strength of its new iPhone 17. Counterpoint Research data show the iPhone 17 line (launched in September) outsold the iPhone 16 series by 14% in their first 10 days on the U.S. and Chinese markets reuters.com investing.com. In particular, the entry-level iPhone 17 has been a smash hit – Chinese demand for the basic model nearly doubled versus last year cnnbrasil.com.br investing.com. Counterpoint senior analyst Mengmeng Zhang credits its “excellent cost-benefit” and strong specs (new A19 chip, bigger screen and storage) at the same price as 2024 investing.com. As one consumer note, Apple even
Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Robust Q3 Results and Increased Guidance Lockheed Martin’s (NYSE:LMT) Oct. 21 earnings release blew past forecasts, reflecting surging military demand. Revenue rose 8.8% year-over-year to $18.61 billion and net income was $6.95/share seattlepi.com. That beat Wall Street’s $6.33/share estimate and matched analyst forecasts of about $18.56 billion. CEO Jim Taiclet highlighted the “unprecedented demand” for Lockheed products, noting a record $179 billion backlog – over 2½ years of sales news.lockheedmartin.com. In light of the strong quarter, Lockheed raised 2025 guidance. It now expects $22.15–$22.35 EPS (vs prior $21.70–$22.00) and about $74.25–$74.75 billion in revenue reuters.com. Jim Taiclet emphasized the scale of current demand: “Based
UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

Stock Price Snapshot: October 2025 Rebound UnitedHealth stock has seen volatile swings in 2025, but recent weeks brought a measure of relief. As of Oct. 21, shares trade around $364, up from the lows hit earlier in the year. On Monday (Oct. 20), UNH jumped +2.21% to close at $364.48investing.com, recovering from a mid-month dip. Over the past week the stock oscillated in the mid-$350s to $360s, essentially flat to slightly higher overallinvesting.com. Despite this stabilization, UnitedHealth remains deep in the red for 2025. The stock is still down roughly 30–35% year-to-date (depending on the reference point)ts2.tech, dramatically underperforming the
21 October 2025
Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Stock Price & Recent Performance Equifax’s stock has been range-bound in recent weeks, hovering in the low-$230s per share. It closed at $231.12 on Oct. 20investing.com, and despite a solid year-to-date performance in 2025, shares remain about 15% lower than a year agoinvesting.com. Elevated interest rates and recession worries weighed on credit industry stocks earlier this year. However, sentiment has improved recently as the Federal Reserve’s policy outlook turned more dovish this fall and tech-focused stocks rebounded. Equifax stock is up roughly 2% for 2025 so far, outperforming some peers, and has climbed about 50% over the past five years
21 October 2025
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Earnings Beat Drives Stock Higher Elevance Health posted strong third-quarter 2025 results, significantly outperforming market expectations on both profit and revenue. Adjusted earnings came in at $6.03 per share, well above the ~$4.95 analysts predictedinvesting.com. Likewise, revenue for the quarter reached $50.1 billion, surpassing the $49.3 billion consensus and growing 12% year-over-yearinvesting.com. This robust growth was fueled by higher premium yields and an expanding customer base – particularly gains in Medicare Advantage enrollments – along with contributions from recent acquisitions in Elevance’s Carelon health services unittradingview.com. These factors combined to help Elevance smash its Q3 forecasts, showcasing strong demand and pricing power
21 October 2025
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher Stock Price and Recent Performance Danaher’s shares have been on a steady climb in recent weeks, hovering around the $208 mark as of October 21, 2025. This puts the stock roughly back to early-year levels and marks a solid rebound from its summer lows. In fact, DHR has gained about 8% over the past month and 10% over the past quarter, outpacing many peers in the life sciences sectorts2.tech. This rally suggests renewed investor interest in Danaher and its industry, possibly driven by anticipation of the Q3 earnings and optimism around new product developments. Despite the recent uptick, it’s
21 October 2025
GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

GM Stock Surges on Q3 Earnings Beat A water tower with the GM logo stands over a General Motors facility. GM’s stock jumped after the automaker’s Q3 2025 earnings topped expectations and guidance was raised, signaling resilience despite industry headwindsng.investing.comng.investing.com. General Motors shares soared in Tuesday’s trading after the Detroit automaker delivered a surprise earnings beat for the third quarter and upgraded its outlook for the year. By midday, GM’s stock price was up about 6.6%, hovering around $61–$62 per share – among its biggest single-day gains of 2025. This jump brings the stock within a whisker of its 52-week
21 October 2025
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

Stock Performance & Recent Moves 3M’s stock has been grinding higher in 2025 after a rough prior decade. Shares are hovering in the mid-$150s – near their highest levels of the past year, though still below pre-2020 peaks. As of the Oct. 20 close, MMM was at $154.78, having climbed about +17.5% in the past 12 monthsca.investing.com. By comparison, the S&P 500 is up roughly mid-teens percentage over a similar period (so 3M has slightly outperformed the broader market). Year-to-date, 3M’s gains are in the high single digits to low teens range, depending on the baseline – a notable improvement
Lynas Rare Earths (LYSCF) Stock Soars on $8.5B U.S.–Australia Rare-Earth Pact

Lynas Rare Earths (LYSCF) Stock Soars on $8.5B U.S.–Australia Rare-Earth Pact

Full Story: Below we examine Lynas Rare Earths’ recent news flow, stock trends, growth plans, and expert analysis in detail. Stock Performance & Recent Trend Lynas shares have been on a tear. By mid-October 2025, the stock (ASX: LYC) had nearly tripled in a year (from ≈A$6 in late 2024 to ~$19) Investing ts2.tech. In early October it spiked to A$21.96 (its highest since 2011) Investing on the magnet-chain MoU, then eased back to ~$18–19 as traders locked in profits ts2.tech. In late Oct 20–21 trading it jumped again (+15% on Oct 20) Stockanalysis. By Oct 21 LYC was ~A$19 (US$14) Investing
21 October 2025
IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank Share Price Skyrockets on Strong Q2 Earnings IDFC First Bank’s stock has been on a tear, soaring about 7% in a single session after the lender delivered stellar Q2 FY2025-26 results. On October 20, the share price hit approximately ₹77 – its highest level in nearly 11 months – as investors cheered a 75% jump in quarterly profitmoneycontrol.com. This upbeat earnings surprise sparked a rally that far outpaced the broader market and peer banks. In fact, IDFC First was the top gainer among major private lenders following the Q2 results: its ~5–7% surge on the day eclipsed
21 October 2025
HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

Stock Performance & Dividend Announcement HTCR’s stock surged on Oct. 20, 2025, when the company revealed the $0.13/share dividend globenewswire.com. In after-hours trading, the share price jumped roughly 40% investing.com. (According to Investing.com, HeartCore stock “surged 40% in after-hours trading on Monday” after the dividend news investing.com.) By Oct. 21, HTCR traded around $0.71 reuters.com. The stock’s 52-week range is $0.39–$3.38 stockanalysis.com, reflecting swings earlier this year (it spiked above $3 in early 2025 before retreating). The dividend announcement itself was a headline event. In a GlobeNewswire release on Oct. 20, HeartCore said the one-time $0.13 payment represents ~17.8% of
21 October 2025
ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank Share Price Today: Mild Dip After Recent Slide As of October 21, 2025, ICICI Bank’s stock traded around ₹1,380 per share, slightly in the red for the daylivemint.com. The price is down about 0.5% from the previous close of ~₹1,390, continuing to linger after a sharp fall on Monday. On October 20, the stock plunged over 3% intraday, hitting lows near ₹1,389 before closing around ₹1,390.90hindustantimes.com. This drop erased gains from the prior week – ICICI had been trading above ₹1,430 last Friday before earnings. Despite the recent volatility, the stock remains up roughly 8–9% in 2025 so
21 October 2025
South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

Stock Hits a New Peak on Earnings Momentum South Indian Bank’s stock price has been on fire, soaring to an all-time high this week on the back of strong earnings and bullish investor sentiment. On October 21, the scrip touched approximately ₹38.4 during the Muhurat trading session (an auspicious one-hour market session on Diwali), building on the previous day’s big gainslivemint.com. At ₹38+, the share is trading at levels never seen before in the bank’s historybusinesstoday.in. For context, the stock was hovering around ₹32 just before the results – meaning it’s leapt about 15–18% in two trading sessions alone. This

Stock Market Today

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

8 February 2026
Deutsche Telekom shares fell 1.1% to 30.26 euros Friday, despite the company repurchasing 250,873 shares for about 7.63 million euros on Xetra. The drop came as European stocks rose and T-Mobile US shares slipped 2.2%. Deutsche Telekom’s 2025 results are due Feb. 26. The company has completed its 2025 buyback and launched a new 2 billion euro programme for 2026.
Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

8 February 2026
Airbus shares rose 0.94% to 191.30 euros Friday as the company reported 19 aircraft deliveries in January, down from 25 a year earlier. Supply chain bottlenecks remain an issue, with executives at the Singapore Airshow calling delays “unacceptable.” Jefferies kept a Neutral rating and a 215-euro price target. Airbus will report full-year 2025 results on Feb. 19.
Go toTop